To study the safety, efficacy and trends in index procedures leading to salvage holmium laser enucleation of the prostate (S-HoLEP).
This was a single-institution retrospective review of HoLEPs performed between 2006 and 2020. Patients who underwent S-HoLEP were compared to those undergoing primary holmium laser enucleation of the prostate (P-HoLEP). The endpoint of primary interest were functional outcomes. Changes in index procedures over the study period were analyzed.
A total of 633 HoLEPs were performed during the study, with 217 being S-HoLEP. The S-HoLEP cohort was older than P-HoLEP cohort, 71.2 years vs 68.8 years (p = 0.03). All other factors were well matched. The most common index procedures prior to S-HoLEP included transurethral resection of the prostate (TURP) (87, 40.1%), transurethral microwave thermotherapy (TUMT) (44, 20.3%), photoselective vaporization of the prostate (PVP) (24, 11.1%) and prostatic urethral lift (PUL) (24, 11.1%). Preoperative prostate volume, IPSS and Qmax were similar between groups. Intra-operatively, S-HoLEP had longer procedure and morcellation times (p = 0.01 and 0.007). Postoperatively, the S-HoLEP cohort had longer catheter duration and hospitalization (both p < 0.001). Postoperative Qmax, IPSS and 90-day complication rates were similar. On temporal analysis, minimally invasive surgical therapies (MIST) have become more prevalent as index procedures.
S-HoLEP is safe and efficacious for patients requiring additional BPH surgical intervention. S-HoLEP patients had longer operative times and hospital stays but equivalent postoperative functional outcomes compared to P-HoLEP. As MIST mature and gain traction, it is expected that rates of S-HoLEP will continue to rise.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Malaeb BS, Yu X, McBean AM, Elliott SP (2012) National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000–2008). Urology. https://doi.org/10.1016/j.urology.2011.11.084
Teo JS, Lee YM, Ho HSS (2017) An update on transurethral surgery for benign prostatic obstruction. Asian J Urol. https://doi.org/10.1016/j.ajur.2017.06.006
Bortnick E, Brown C, Simma-Chiang V, Kaplan SA (2020) Modern best practice in the management of benign prostatic hyperplasia in the elderly. Ther Adv Urol. https://doi.org/10.1177/1756287220929486
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol. https://doi.org/10.1016/j.eururo.2005.12.042
Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ (2000) Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the patient outcomes research team for prostatic diseases. J Urol 164:1212–1215
Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF et al (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. https://doi.org/10.1056/nejm198904273201705
Tanneru K, Gautam S, Norez D, Kumar J, Alam MU, Koocheckpour S et al (2020) Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. Int Urol Nephrol. https://doi.org/10.1007/s11255-020-02408-y
Miller LE, Chughtai B, Dornbier RA, McVary KT (2020) Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol. https://doi.org/10.1097/JU.0000000000001132
Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 24:8802–8813
Kaplan S (2019) DeMISTifying less-invasive solutions for BPH. Urol Times J 47:22–24
McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM et al (2021) Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. https://doi.org/10.1097/JU.0000000000001778
Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J Urol. https://doi.org/10.1097/JU.0000000000002184
Ahyai SA, Lehrich K, Kuntz RM (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. https://doi.org/10.1016/j.eururo.2007.04.053
Cornu JN, Ahyai S, Bachmann A, De La Rosette J, Gilling P, Gratzke C et al (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. https://doi.org/10.1016/j.eururo.2014.06.017
Elzayat EA, Elhilali MM (2007) Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol. https://doi.org/10.1016/j.eururo.2007.04.074
Rivera M, Krambeck A, Lingeman J (2017) Holmium laser enucleation of the prostate in patients requiring anticoagulation. Curr Urol Rep. https://doi.org/10.1007/s11934-017-0727-2
Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE (2008) Holmium laser enucleation of the prostate-outcomes independent of prostate size? J Urol. https://doi.org/10.1016/j.juro.2008.08.019
Oh JK, Bae J, Jeong CW, Paick JS, Oh SJ (2014) Salvage holmium laser enucleation of prostate to treat residual benign prostatic hyperplasia. J Can Urol Assoc. https://doi.org/10.5489/cuaj.1494
Marien T, Kadihasanoglu M, Tangpaitoon T, York N, Blackburne AT, Abdul-Muhsin H et al (2017) Outcomes of holmium laser enucleation of the prostate in the re-treatment setting. J Urol. https://doi.org/10.1016/j.juro.2016.12.098
Jaeger CD, Krambeck AE (2013) Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery. Urology. https://doi.org/10.1016/j.urology.2013.01.019
Elshal AM, Elmansy HM, Elhilali MM (2012) Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). BJU Int. https://doi.org/10.1111/j.1464-410X.2012.11290.x
Page T, Veeratterapillay R, Keltie K, Burn J, Sims A (2021) Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics. BMC Urol. https://doi.org/10.1186/s12894-021-00824-5
Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management. J Urol. https://doi.org/10.1097/JU.0000000000002183
Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M et al (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial. Radiology. https://doi.org/10.1148/radiol.13122803
Feng S, Tian Y, Liu W, Li Z, Deng T, Li H et al (2017) Prostatic arterial embolization treating moderate-to-severe lower urinary tract symptoms related to benign prostate hyperplasia: a meta-analysis. Cardiovasc Intervent Radiol. https://doi.org/10.1007/s00270-016-1516-x
Carnevale FC, Moreira AM, De Assis AM, Antunes AA, De Paula Rodrigues VC, Srougi M et al (2020) Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years’ experience. Radiology. https://doi.org/10.1148/radiol.2020191249
Large T, Krambeck AE (2018) Evidence-based outcomes of holmium laser enucleation of the prostate. Curr Opin Urol. https://doi.org/10.1097/MOU.0000000000000498
McAdams S, Funk JT, Navetta AF, El Tayeb MM, Humphreys MR (2017) Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series. J Endourol. https://doi.org/10.1089/end.2017.0224
No funding was received to assist in preparation of this manuscript.
Conflict of interest
All authors declare no financial disclosures or non-financial competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Durant, A.M., Moore, J., Voleti, S. et al. Salvage versus primary holmium laser enucleation of the prostate: trends, outcomes and safety analysis. World J Urol 40, 2305–2312 (2022). https://doi.org/10.1007/s00345-022-04098-w